Trial · NCT02540993
Adverse events1,934
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,934
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Finerenone | 201 | 2,827 | 218 |
| other | Anaemia | Blood and lymphatic system disorders | Placebo | 177 | 2,831 | 196 |
| other | Constipation | Gastrointestinal disorders | Finerenone | 128 | 2,827 | 146 |
| other | Constipation | Gastrointestinal disorders | Placebo | 162 | 2,831 | 179 |
| other | Diarrhoea | Gastrointestinal disorders | Finerenone | 183 | 2,827 | 216 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo | 188 | 2,831 | 224 |
| other | Oedema peripheral | General disorders | Finerenone | 183 | 2,827 | 216 |
| other | Oedema peripheral | General disorders | Placebo | 303 | 2,831 | 359 |
| other | Bronchitis | Infections and infestations | Finerenone | 127 | 2,827 | 140 |
| other | Bronchitis | Infections and infestations | Placebo | 142 | 2,831 | 188 |
| other | Nasopharyngitis | Infections and infestations | Finerenone | 241 | 2,827 | 368 |
| other | Nasopharyngitis | Infections and infestations | Placebo | 250 | 2,831 | 391 |
| other | Upper respiratory tract infection | Infections and infestations | Finerenone | 181 | 2,827 | 274 |
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 185 | 2,831 | 262 |
| other | Urinary tract infection | Infections and infestations | Finerenone | 168 | 2,827 | 215 |
| other | Urinary tract infection | Infections and infestations | Placebo | 185 | 2,831 | 259 |
| other | Glomerular filtration rate decreased | Investigations | Finerenone | 177 | 2,827 | 225 |
| other | Glomerular filtration rate decreased | Investigations | Placebo | 130 | 2,831 | 146 |
| other | Hyperkalaemia | Metabolism and nutrition disorders | Finerenone | 422 | 2,827 | 634 |
| other | Hyperkalaemia | Metabolism and nutrition disorders | Placebo | 212 | 2,831 | 281 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02540993/events